Fundz

Theolytics raised £19M in a funding round to advance THEO-260 into clinical trials for ovarian cancer treatment

PRIVATEApr 17, 2024

Amount Raised

£19 Million

Round Type

Funding Round

OxfordBiotechnologyHealth Care

Investors

University Of OxfordOxford Science EnterprisesEpidarex CapitalTaiho VenturesM VenturesSound Bioventures

Description

Theolytics, a biotechnology company based in Oxford, UK, has raised £19M in funding. The funding round included backers such as Sound Bioventures, M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises, and the University of Oxford. The company plans to use the funds to advance THEO-260 into clinical trials for treating ovarian cancer, aiming to provide better outcomes for patients.

Quick answer

Theolytics raised £19 Million in a Funding Round round, dated April 17, 2024. Investors: University Of Oxford, Oxford Science Enterprises, Epidarex Capital, Taiho Ventures, M Ventures and Sound Bioventures. Theolytics is based in Oxford, England, United Kingdom.

How much did Theolytics raise?
Theolytics raised £19 Million in a Funding Round round on April 17, 2024.
Who invested in Theolytics?
University Of Oxford, Oxford Science Enterprises, Epidarex Capital, Taiho Ventures, M Ventures and Sound Bioventures are named as investors in this round.
What does Theolytics do?
Theolytics is a biotechnology company focused on developing category changing cancer therapies in the form of oncolytic viruses.
Where is Theolytics based and how big is it?
Theolytics is based in Oxford, England, United Kingdom. Fundz records about 29 employees.
Who are the decision-makers at Theolytics?
Fundz holds 2 contacts at Theolytics, including the Head of Business Operations. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Theolytics that raised within 45 days of this round, from Fundz verified event records.

  • Ignitedata (Delaware) raised $500K (Seed) on May 31, 2024.
  • Aveta Biomics raised $4.5M on May 30, 2024.
  • Streamex Corp. raised $3M (Seed) on May 29, 2024.
  • Matter Bio raised $7M (Seed) on May 29, 2024.
  • Gameto raised $33M (Series B) on May 29, 2024.
  • Radiomer Therapeutics raised an undisclosed amount (Pre-Seed) on May 29, 2024.

Who to call at Theolytics, and when

A new round usually means Theolytics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Theolytics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Theolytics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Theolytics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Theolytics

Location

Oxford, England, United Kingdom

About

Theolytics is a biotechnology company focused on developing category changing cancer therapies in the form of oncolytic viruses. The company is pioneering a phenotypic screening approach to the discovery and development of efficacious, targeted candidates suitable for systemic intravenous delivery and optimized for a chosen patient population. Theolytics, which was founded in 2017 and is headquartered in Oxford, UK, is backed by Oxford Science Enterprises and international life sciences investors Epidarex Capital, M Ventures and Taiho Ventures.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Theolytics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsRose, Head of Business Operations hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Theolytics's next move

See what Strategic adds

Theolytics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.